4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-030308
Executive VP, Global R&D sold 130,000 shares at $8.22 ($1,068,067)
From the SEC's structured data for this filing
Trades in this filing
Fridriksdottir Hafrun · Executive VP, Global R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-17 | Sale : show line 1 in the form | −130,000 | $8.22 | $1,068,067 | 1,386.51 | D |
| Open-market sales · 130,000 sh · avg $8.22 · $1,068,067 | ||||||
Loading xslF345X03/doc4.xml…